Neuronal FLT1 receptor and its selective ligand VEGFB protect against retrograde degeneration of sensory neurons

FASEB Journal

Volumn 25, Issue 5, 2011, Pages 1461-1473

  Dhondt, Joke ^a,b   Peeraer, Eve ^c,d   Verheyen, An ^a,b,c   Nuydens, Rony ^c   Buysschaert, Ian ^a,b   Poesen, Koen ^a,b   Van Geyte, Katie ^a,b   Beerens, Manu ^a,b   Shibuya, Masabumi ^e   Haigh, Jody J ^b,f   Meert, Theo ^c   Carmeliet, Peter ^a,b   Lambrechts, Diether ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^d HASSELT UNIVERSITY   (Belgium)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f GHENT UNIVERSITY   (Belgium)

Author keywords

Distal neuropathy; Neurovascular link

Indexed keywords

PACLITAXEL; VASCULOTROPIN B; VASCULOTROPIN RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DEATH; CELL STRESS; CONTROLLED STUDY; DISTAL NEUROPATHY; GENE TRANSFER; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NERVE CELL DEGENERATION; NERVE CELL STIMULATION; NEUROPATHY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE CELL; SPINAL GANGLION; VASCULARIZATION;

ANIMALS; IMMUNOHISTOCHEMISTRY; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYNEUROPATHIES; RATS; RATS, SPRAGUE-DAWLEY; RETROGRADE DEGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSORY RECEPTOR CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

MUS;

EID: 79955655849     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-170944     Document Type: Article

References (38)

1. Lahteenvuo, J. E., Lahteenvuo, M. T., Kivela, A., Rosenlew, C., Falkevall, A., Klar, J., Heikura, T., Rissanen, T. T., Vahakangas, E., Korpisalo, P., Enholm, B., Carmeliet, P., Alitalo, K., Eriksson, U., and Yla-Herttuala, S. (2009) Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms. Circulation 119, 845-856
2. Li, X., Tjwa, M., Van Hove, I., Enholm, B., Neven, E., Paavonen, K., Jeltsch, M., Juan, T. D., Sievers, R. E., Chorianopoulos, E., Wada, H., Vanwildemeersch, M., Noel, A., Foidart, J. M., Springer, M. L., von Degenfeld, G., Dewerchin, M., Blau, H. M., Alitalo, K., Eriksson, U., Carmeliet, P., and Moons, L. (2008) Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arterioscler. Thromb. Vasc. Biol. 28, 1614-1620
3. Zentilin, L., Puligadda, U., Lionetti, V., Zacchigna, S., Collesi, C., Pattarini, L., Ruozi, G., Camporesi, S., Sinagra, G., Pepe, M., Recchia, F. A., and Giacca, M. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J. 24, 1467-1478
4. Mould, A. W., Tonks, I. D., Cahill, M. M., Pettit, A. R., Thomas, R., Hayward, N. K., and Kay, G. F. (2003) Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis Rheum. 48, 2660-2669
5. Hagberg, C. E., Falkevall, A., Wang, X., Larsson, E., Huusko, J., Nilsson, I., van Meeteren, L. A., Samen, E., Lu, L., Vanwildemeersch, M., Klar, J., Genove, G., Pietras, K., Stone-Elander, S., Claesson-Welsh, L., Yla-Herttuala, S., Lindahl, P., and Eriksson, U. Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 464, 917-921
6. Falk, T., Zhang, S., and Sherman, S. J. (2009) Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease. Mol. Neurodegener. 4, 49
7. Poesen, K., Lambrechts, D., Van Damme, P., Dhondt, J., Bender, F., Frank, N., Bogaert, E., Claes, B., Heylen, L., Verheyen, A., Raes, K., Tjwa, M., Eriksson, U., Shibuya, M., Nuydens, R., Van Den Bosch, L., Meert, T., D'Hooge, R., Sendtner, M., Robberecht, W., and Carmeliet, P. (2008) Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J. Neurosci. 28, 10451-10459
8. Li, Y., Zhang, F., Nagai, N., Tang, Z., Zhang, S., Scotney, P., Lennartsson, J., Zhu, C., Qu, Y., Fang, C., Hua, J., Matsuo, O., Fong, G. H., Ding, H., Cao, Y., Becker, K. G., Nash, A., Heldin, C. H., and Li, X. (2008) VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3- only protein genes in mice and rats. J. Clin. Invest. 118, 913-923
9. Carmeliet, P., and Tessier-Lavigne, M. (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436, 193-200 (Pubitemid 41021263)
10. Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M., and Carmeliet, P. (2009) Role and therapeutic potential of VEGF in the nervous system. Physiol. Rev. 89, 607-648
11. Zacchigna, S., Lambrechts, D., and Carmeliet, P. (2008) Neurovascular signalling defects in neurodegeneration. Nat. Rev. Neurosci. 9, 169-181
12. Valable, S., Bellail, A., Lesne, S., Liot, G., Mackenzie, E. T., Vivien, D., Bernaudin, M., and Petit, E. (2003) Angiopoietin-1- induced PI3-kinase activation prevents neuronal apoptosis. FASEB J. 17, 443-445
13. Mukouyama, Y. S., Shin, D., Britsch, S., Taniguchi, M., and Anderson, D. J. (2002) Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 109, 693-705 (Pubitemid 34722266)
14. Schratzberger, P., Schratzberger, G., Silver, M., Curry, C., Kearney, M., Magner, M., Alroy, J., Adelman, L. S., Weinberg, D. H., Ropper, A. H., and Isner, J. M. (2000) Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat. Med. 6, 405-413
15. Schratzberger, P., Walter, D. H., Rittig, K., Bahlmann, F. H., Pola, R., Curry, C., Silver, M., Krainin, J. G., Weinberg, D. H., Ropper, A. H., and Isner, J. M. (2001) Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest. 107, 1083-1092
16. Kirchmair, R., Tietz, A. B., Panagiotou, E., Walter, D. H., Silver, M., Yoon, Y. S., Schratzberger, P., Weber, A., Kusano, K., Weinberg, D. H., Ropper, A. H., Isner, J. M., and Losordo, D. W. (2007) Therapeutic angiogenesis inhibits or rescues chemotherapy- induced peripheral neuropathy: taxol- and thalidomideinduced injury of vasa nervorum is ameliorated by VEGF. Mol. Ther. 15, 69-75
17. Sondell, M., Sundler, F., and Kanje, M. (2000) Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J. Neurosci. 12, 4243-4254
18. Srinivas, S., Watanabe, T., Lin, C. S., William, C. M., Tanabe, Y., Jessell, T. M., and Costantini, F. (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4
19. George, S. H., Gertsenstein, M., Vintersten, K., Korets-Smith, E., Murphy, J., Stevens, M. E., Haigh, J. J., and Nagy, A. (2007) Developmental and adult phenotyping directly from mutant embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 104, 4455-4460
20. Tschachler, E., Reinisch, C. M., Mayer, C., Paiha, K., Lassmann, H., and Weninger, W. (2004) Sheet preparations expose the dermal nerve plexus of human skin and render the dermal nerve end organ accessible to extensive analysis. J. Invest. Dermatol. 122, 177-182
21. Tsujino, H., Kondo, E., Fukuoka, T., Dai, Y., Tokunaga, A., Miki, K., Yonenobu, K., Ochi, T., and Noguchi, K. (2000) Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol. Cell. Neurosci. 15, 170-182
22. Peters, C. M., Jimenez-Andrade, J. M., Jonas, B. M., Sevcik, M. A., Koewler, N. J., Ghilardi, J. R., Wong, G. Y., and Mantyh, P. W. (2007) Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp. Neurol. 203, 42-54
23. Wilson, K., Geenen, F., Biermans, R., Nuydens, R., and Meert, T. (2006) Sensory dysfunctions after topical application of cytostastic: a new model for the study of peripheral neuropathies. Int. J. Neuroprot. Neurodegen. 3, 31-36
24. Bernardi, P., Scorrano, L., Colonna, R., Petronilli, V., and Di Lisa, F. (1999) Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur. J. Biochem. 264, 687-701
25. Soriano, P. (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71
26. Popovici, C., Isnardon, D., Birnbaum, D., and Roubin, R. (2002) Caenorhabditis elegans receptors related to mammalian vascular endothelial growth factor receptors are expressed in neural cells. Neurosci. Lett. 329, 116-120
27. Sun, Y., Jin, K., Childs, J. T., Xie, L., Mao, X. O., and Greenberg, D. A. (2006) Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. Dev. Biol. 289, 329-335
28. Sun, Y., Jin, K., Childs, J. T., Xie, L., Mao, X. O., and Greenberg, D. A. (2004) Increased severity of cerebral ischemic injury in vascular endothelial growth factor-B-deficient mice. J. Cereb. Blood Flow. Metab. 24, 1146-1152
29. Kirchmair, R., Walter, D. H., Ii, M., Rittig, K., Tietz, A. B., Murayama, T., Emanueli, C., Silver, M., Wecker, A., Amant, C., Schratzberger, P., Yoon, Y. S., Weber, A., Panagiotou, E., Rosen, K. M., Bahlmann, F. H., Adelman, L. S., Weinberg, D. H., Ropper, A. H., Isner, J. M., and Losordo, D. W. (2005) Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth. Circulation 111, 2662-2670
30. Kerbel, R. S. (2008) Tumor angiogenesis. N. Engl. J. Med. 358, 2039-2049
31. Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438, 932-936
32. Lipton, S. A. (2004) Erythropoietin for neurologic protection and diabetic neuropathy. N. Engl. J. Med. 350, 2516-2517
33. Bennett, C. L., Silver, S. M., Djulbegovic, B., Samaras, A. T., Blau, C. A., Gleason, K. J., Barnato, S. E., Elverman, K. M., Courtney, D. M., McKoy, J. M., Edwards, B. J., Tigue, C. C., Raisch, D. W., Yarnold, P. R., Dorr, D. A., Kuzel, T. M., Tallman, M. S., Trifilio, S. M., West, D. P., Lai, S. Y., and Henke, M. (2008) Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299, 914-924 (Pubitemid 351397066)
34. Shu, X. Q., and Mendell, L. M. (1999) Neurotrophins and hyperalgesia. Proc. Natl. Acad. Sci. U. S. A. 96, 7693-7696
35. Argyriou, A. A., Koltzenburg, M., Polychronopoulos, P., Papapetropoulos, S., and Kalofonos, H. P. (2008) Peripheral nerve damage associated with administration of taxanes in patients with cancer. Crit. Rev. Oncol. Hematol. 66, 218-228
36. Silvestre, J. S., Tamarat, R., Ebrahimian, T. G., Le-Roux, A., Clergue, M., Emmanuel, F., Duriez, M., Schwartz, B., Branellec, D., and Levy, B. I. (2003) Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ. Res. 93, 114-123
37. Li, Y., Zhang, F., Nagai, N., Tang, Z., Zhang, S., Scotney, P., Lennartsson, J., Zhu, C., Qu, Y., Fang, C., Hua, J., Matsuo, O., Fong, G. H., Ding, H., Cao, Y., Becker, K. G., Nash, A., Heldin, C. H., and Li, X. (2008) VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3- only protein genes in mice and rats. J. Clin. Invest. 118, 913-923
38. Kanda, M., Nomoto, S., Nishikawa, Y., Sugimoto, H., Kanazumi, N., Takeda, S., and Nakao, A. (2008) Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. J. Surg. Oncol. 98, 190-196